CN1182348A - 产生耐渗透性植物的方法 - Google Patents
产生耐渗透性植物的方法 Download PDFInfo
- Publication number
- CN1182348A CN1182348A CN96193502A CN96193502A CN1182348A CN 1182348 A CN1182348 A CN 1182348A CN 96193502 A CN96193502 A CN 96193502A CN 96193502 A CN96193502 A CN 96193502A CN 1182348 A CN1182348 A CN 1182348A
- Authority
- CN
- China
- Prior art keywords
- plants
- gene
- betaine
- salt
- choline oxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 230000003204 osmotic effect Effects 0.000 title description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 61
- 108010000659 Choline oxidase Proteins 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000013598 vector Substances 0.000 claims abstract description 14
- 241000196324 Embryophyta Species 0.000 claims description 124
- 150000003839 salts Chemical class 0.000 claims description 33
- 230000000694 effects Effects 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 241000186063 Arthrobacter Species 0.000 claims description 10
- 241000192700 Cyanobacteria Species 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 241000209510 Liliopsida Species 0.000 claims description 4
- 241000219198 Brassica Species 0.000 claims description 3
- 241001233957 eudicotyledons Species 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 241001478887 unidentified soil bacteria Species 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 abstract description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 98
- 101150093170 codA gene Proteins 0.000 description 59
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 57
- 229960003237 betaine Drugs 0.000 description 50
- 240000007594 Oryza sativa Species 0.000 description 30
- 239000011780 sodium chloride Substances 0.000 description 29
- 235000007164 Oryza sativa Nutrition 0.000 description 27
- 235000009566 rice Nutrition 0.000 description 25
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- 229930002875 chlorophyll Natural products 0.000 description 21
- 235000019804 chlorophyll Nutrition 0.000 description 21
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 21
- 230000000243 photosynthetic effect Effects 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 21
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 19
- 239000000600 sorbitol Substances 0.000 description 19
- 241000192707 Synechococcus Species 0.000 description 18
- 229960001231 choline Drugs 0.000 description 16
- 230000012010 growth Effects 0.000 description 15
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 14
- 230000009471 action Effects 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 241000192589 Synechococcus elongatus PCC 7942 Species 0.000 description 12
- 230000015784 hyperosmotic salinity response Effects 0.000 description 10
- 210000000349 chromosome Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 8
- 241000219194 Arabidopsis Species 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229930027917 kanamycin Natural products 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 206010020649 Hyperkeratosis Diseases 0.000 description 6
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 6
- 210000003763 chloroplast Anatomy 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 229960000268 spectinomycin Drugs 0.000 description 5
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 235000019743 Choline chloride Nutrition 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 4
- 244000300264 Spinacia oleracea Species 0.000 description 4
- 235000009337 Spinacia oleracea Nutrition 0.000 description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 4
- 229960003178 choline chloride Drugs 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 108010061238 threonyl-glycine Proteins 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- 241000135402 Synechococcus elongatus PCC 6301 Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000002701 cell growth assay Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102100024085 Alpha-aminoadipic semialdehyde dehydrogenase Human genes 0.000 description 2
- 108010049668 Betaine-Aldehyde Dehydrogenase Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- SXKNCCSPZDCRFD-UHFFFAOYSA-N betaine aldehyde Chemical compound C[N+](C)(C)CC=O SXKNCCSPZDCRFD-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108091027963 non-coding RNA Proteins 0.000 description 2
- 102000042567 non-coding RNA Human genes 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000002786 root growth Effects 0.000 description 2
- 238000010850 salt effect Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 244000000000 soil microbiome Species 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000003971 tillage Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000005074 turgor pressure Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- 229940005561 1,4-benzoquinone Drugs 0.000 description 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 description 1
- 101710191936 70 kDa protein Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 1
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 1
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 1
- BVSGPHDECMJBDE-HGNGGELXSA-N Ala-Glu-His Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N BVSGPHDECMJBDE-HGNGGELXSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 1
- OKEWAFFWMHBGPT-XPUUQOCRSA-N Ala-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CN=CN1 OKEWAFFWMHBGPT-XPUUQOCRSA-N 0.000 description 1
- VGMNWQOPSFBBBG-XUXIUFHCSA-N Ala-Leu-Leu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O VGMNWQOPSFBBBG-XUXIUFHCSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- KQESEZXHYOUIIM-CQDKDKBSSA-N Ala-Lys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KQESEZXHYOUIIM-CQDKDKBSSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- XAXHGSOBFPIRFG-LSJOCFKGSA-N Ala-Pro-His Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O XAXHGSOBFPIRFG-LSJOCFKGSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 1
- DGFGDPVSDQPANQ-XGEHTFHBSA-N Arg-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N)O DGFGDPVSDQPANQ-XGEHTFHBSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 1
- RIQBRKVTFBWEDY-RHYQMDGZSA-N Arg-Lys-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RIQBRKVTFBWEDY-RHYQMDGZSA-N 0.000 description 1
- VVJTWSRNMJNDPN-IUCAKERBSA-N Arg-Met-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O VVJTWSRNMJNDPN-IUCAKERBSA-N 0.000 description 1
- XEOXPCNONWHHSW-AVGNSLFASA-N Arg-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N XEOXPCNONWHHSW-AVGNSLFASA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- 241000186074 Arthrobacter globiformis Species 0.000 description 1
- 241000186001 Arthrobacter pascens Species 0.000 description 1
- HCAUEJAQCXVQQM-ACZMJKKPSA-N Asn-Glu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HCAUEJAQCXVQQM-ACZMJKKPSA-N 0.000 description 1
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 1
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 1
- VLDRQOHCMKCXLY-SRVKXCTJSA-N Asn-Ser-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VLDRQOHCMKCXLY-SRVKXCTJSA-N 0.000 description 1
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 1
- MFMJRYHVLLEMQM-DCAQKATOSA-N Asp-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N MFMJRYHVLLEMQM-DCAQKATOSA-N 0.000 description 1
- YTXCCDCOHIYQFC-GUBZILKMSA-N Asp-Met-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTXCCDCOHIYQFC-GUBZILKMSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- OTKUAVXGMREHRX-CFMVVWHZSA-N Asp-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 OTKUAVXGMREHRX-CFMVVWHZSA-N 0.000 description 1
- VHUKCUHLFMRHOD-MELADBBJSA-N Asp-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O VHUKCUHLFMRHOD-MELADBBJSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- 108020001540 Choline monooxygenase Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- LYSHSHHDBVKJRN-JBDRJPRFSA-N Cys-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CS)N LYSHSHHDBVKJRN-JBDRJPRFSA-N 0.000 description 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 1
- HKTRDWYCAUTRRL-YUMQZZPRSA-N Glu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-YUMQZZPRSA-N 0.000 description 1
- DNPCBMNFQVTHMA-DCAQKATOSA-N Glu-Leu-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DNPCBMNFQVTHMA-DCAQKATOSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- CAQXJMUDOLSBPF-SUSMZKCASA-N Glu-Thr-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAQXJMUDOLSBPF-SUSMZKCASA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 1
- GVVKYKCOFMMTKZ-WHFBIAKZSA-N Gly-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CN GVVKYKCOFMMTKZ-WHFBIAKZSA-N 0.000 description 1
- DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 1
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- 241001074968 Halobacteria Species 0.000 description 1
- OEROYDLRVAYIMQ-YUMQZZPRSA-N His-Gly-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O OEROYDLRVAYIMQ-YUMQZZPRSA-N 0.000 description 1
- VTZYMXGGXOFBMX-DJFWLOJKSA-N His-Ile-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O VTZYMXGGXOFBMX-DJFWLOJKSA-N 0.000 description 1
- WCHONUZTYDQMBY-PYJNHQTQSA-N His-Pro-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WCHONUZTYDQMBY-PYJNHQTQSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- XLCZWMJPVGRWHJ-KQXIARHKSA-N Ile-Glu-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N XLCZWMJPVGRWHJ-KQXIARHKSA-N 0.000 description 1
- DRCKHKZYDLJYFQ-YWIQKCBGSA-N Ile-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRCKHKZYDLJYFQ-YWIQKCBGSA-N 0.000 description 1
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 1
- 241000976416 Isatis tinctoria subsp. canescens Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 1
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 1
- XOEDPXDZJHBQIX-ULQDDVLXSA-N Leu-Val-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XOEDPXDZJHBQIX-ULQDDVLXSA-N 0.000 description 1
- UETQMSASAVBGJY-QWRGUYRKSA-N Lys-Gly-His Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 UETQMSASAVBGJY-QWRGUYRKSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- VIZLHGTVGKBBKO-AVGNSLFASA-N Met-Arg-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VIZLHGTVGKBBKO-AVGNSLFASA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108050004203 Oxygen-dependent choline dehydrogenases Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- HRIXMVRZRGFKNQ-HJGDQZAQSA-N Pro-Thr-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HRIXMVRZRGFKNQ-HJGDQZAQSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101150041925 RBCS gene Proteins 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 1
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 1
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 1
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 1
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000192593 Synechocystis sp. PCC 6803 Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 1
- XOLLWQIBBLBAHQ-WDSOQIARSA-N Trp-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O XOLLWQIBBLBAHQ-WDSOQIARSA-N 0.000 description 1
- FGJWNBBFAUHBEP-IHPCNDPISA-N Tyr-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N FGJWNBBFAUHBEP-IHPCNDPISA-N 0.000 description 1
- STTVVMWQKDOKAM-YESZJQIVSA-N Tyr-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O STTVVMWQKDOKAM-YESZJQIVSA-N 0.000 description 1
- WOAQYWUEUYMVGK-ULQDDVLXSA-N Tyr-Lys-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOAQYWUEUYMVGK-ULQDDVLXSA-N 0.000 description 1
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 1
- CVUDMNSZAIZFAE-TUAOUCFPSA-N Val-Arg-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N CVUDMNSZAIZFAE-TUAOUCFPSA-N 0.000 description 1
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- KZKMBGXCNLPYKD-YEPSODPASA-N Val-Gly-Thr Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O KZKMBGXCNLPYKD-YEPSODPASA-N 0.000 description 1
- KVRLNEILGGVBJX-IHRRRGAJSA-N Val-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CN=CN1 KVRLNEILGGVBJX-IHRRRGAJSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003126 immunogold labeling Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001033 osmoprotective effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical class I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Control Of Multiple Motors (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Color Printing (AREA)
- Nonmetallic Welding Materials (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
一种产生耐盐性和/或耐渗透性植物的方法,它包括用携带编码胆碱氧化酶的基因的重组载体转化植物的步骤,以及用所述方法产生的耐盐性和/或耐渗透性植物或其有相同特性的子代。
Description
本发明涉及产生具有新颖特性的植物的方法,具体地说,本发明涉及产生耐盐性和/或耐渗透性植物的方法,该植物高度地抗恶劣环境的影响。
防止全球变暖的一种有效方法是绿化未开垦的土壤如沙漠或盐积聚的土。为此,一种方法是开发能抗恶劣环境的植物与如灌溉的工程方法结合,对于控制沙漠的侵蚀、促进绿化和防止全球变暖起重要作用。
盐积聚会引起以下损害作用:(1)积聚的盐降低土壤中的水位从而阻止植物汲取水分;(2)吸收入(渗透入)植物的盐会干扰其代谢作用;(3)盐抑制植物为生长而对其它必需离子的吸收(Sato,F.,PlantCell Engineering,Supplement,“Environmental Problems andPhytobiotechnology”,pp.33-39,1994)。尤其是抑制对水的吸收而导致植物损失膨胀压并关闭气孔。于是,光合作用受破坏且生长严重受抑制。
植物逐渐形成各种机制以使自身适应这类环境。在一个简单的适应模型中,植物细胞以某种方式维持细胞内外的渗压差,并通过吸收水来恢复膨压。例如嗜盐细菌(halobacteria),虽然不是植物,但可通过存储盐来保持细胞内外的渗压平衡。不过此时,它难于使自身适应环境(渗透压的)变化,因为要求胞内代谢酶本身就是耐盐性的。
因此,更好的适应机制是合成称为“相容性溶质”的专一性化合物以保持如许多耐盐性植物那样依赖于外在渗透变化的胞内渗透。
作为相容性溶质,已知的有如甘氨酸甜菜碱(glycinebetaine)或脯氨酸的双极性化合物和多元醇如蒎立醇、山梨醇或甘露醇。这些化合物的特征在于:分子量低、水溶性高、代谢能力低、对代谢作用无影响等等,故适于渗透调节。
其中值得一提的是发现于植物和细菌中作为相容性溶质的甘氨酸甜菜碱(此后文中称为甜菜碱),这些植物和细菌可适应盐积聚和/或缺水的环境。甜菜碱被认为是发现于如藜科、禾本科、茄科的高等植物中,以及蓝细菌(cyanobacteria)、大肠杆菌(Escherichia coli)等等(例如参见Rhodes,D.and Hanson,A.D.,Annu.Rev.Plant Physiol.PlantMol.Biol.44:357-3584,1993)中的相容性溶质。甜菜碱是一种渗透防护性物质,它能保持与环境的渗透平衡(Robinson,S.P.and Jones,G.P.,Aust.J.Plant Physiol.13:659-668,1986)并防止可溶性酶因盐浓度高而引起的离解(Gabbay-Azaria et al.,Arch.Biochem.Biophys,264:333-339,1988)。此外,甜菜碱能通过稳定光合释氧复合体中的相邻蛋白质和锰聚簇而保护光系统II复合体以抗高的盐浓度(例如,参见Murata etal.,FEBS Lett.296:187-189,1992)。
在大肠杆菌和菠菜(Spinacia oleracea)中,甜菜碱是通过示于图1中的两步氧化作用而从胆碱由生物合成的。大肠杆菌含两种脱氢酶:其一是膜结合的依赖于氧的胆碱脱氢酶,它将胆碱氧化成甜菜醛(Landfald,B.and Strom,A.,J.Bacteriol.165:849-855,1986);其二是可溶性、依赖于NAD的甜菜醛脱氢酶,它将甜菜醛氧化成甜菜碱(Falkenberg,P.and Strom,A.R.,Biochim.Biophys.Acta.1034:253-259,1990)。据报道,在高等植物中,甜菜碱是通过类似于大肠杆菌中的途径而合成于叶绿体中。在菠菜(Spinacia oleracea)中,氧化作用的第一步受依赖于铁氧还蛋白的胆碱单加氧酶催化(Brouquisse,R.etal.,Plant Physiol.90:322-329,1989),且业已分离出催化该氧化作用的第二步、依赖于NAD的甜菜醛脱氢酶(Weretilnyk,E.A.etal.,Planta.178:342-352,1989)。已发现这些植物可提高这两种酶的活性,从而提高盐作用(salt stress)下甜菜碱的量(例如参见:Hanson,A.D.etal.Proc.Natl.Acad.Sci.U.S.A.82:3678-3682,1985)。
另外,得自革兰氏阳性土壤细菌球形节杆菌(Arthrobacterglobiformis)的胆碱氧化酶能在一步氧化反应中将胆碱氧化成甜菜碱(Ikuta,S.et al.,J.Biochem.82:1741-1749,1977)。
人们已试图通过将发现于大肠杆菌和高等植物中的这两种基因或胆碱氧化酶基因整合到植物中使之稳定表达这些基因而赋与植物耐盐性(例如参见:Nomura M.et al.,Plant Physiol,107:703-708,1995)。然而,在通过将这类基因整合到植物、尤其是高等植物中以稳定地表达它们而获得耐盐性和/或耐渗透性植物方面,迄今尚未取得成功。
胆碱氧化酶可商购,但它的氨基酸序列尚未被测定。因此,强烈需要测定编码可有效地将胆碱转变成甜菜碱的胆碱氧化酶的基因序列,并将它整合到植物中以使之稳定地表达所述序列,从而产生可耐环境(渗透性)变化如高的盐浓度的植物。
在深入研究该如何解决上述问题之后,本发明人成功地分离出一种编码胆碱氧化酶的新型基因(The Japanese Society of PlantPhysiologist,Annual meeting of 1994,the 34th Symposium held March28-30,1994),并将其整合入蓝细菌,芥属(brassicaceous)植物和禾本科植物以获得耐盐性和/或耐渗透性植物。
因此,本发明提供一种产生耐盐性和/或耐渗透性植物的方法,它包括用携带编码胆碱氧化酶的基因的重组载体转化植物的步骤,还提供依所述方法获得的耐盐性和/或耐渗透性植物。
对图的简要描述
图1表示从胆碱至甜菜碱的氧化过程。
图2A表示转化聚球蓝细菌(Synechococcus)PCC7942用的构建体。PAM是指用pAM1044转化的聚球蓝细菌PCC7942,而PAM COD是指用携带cod A基因的pAM1044转化的聚球蓝细菌PCC7942。虚划箭头指示用于PCR的引物。三角形表示conII启动子。箭头指示基因的取向。
图2B表示SDS-PAGE(电泳照片),它示出染色体被耐壮观霉素的基因和聚球蓝细菌PCC7942的DNA中的cod A基因彻底置换。a栏:λ-HindIII/φx174-HaeIII片段;b栏:聚球蓝细菌PCC7942的野生型菌株;c栏:菌株PAM;d栏和e栏:菌株PAMCOD(b、c和d栏示出应用引物1和2的PCR结果,而e栏显示应用引物1和3的PCR结果)。
图3表示Western印迹分析(电泳照片),示出在聚球蓝细菌菌株PAM和PAMCOD中表达胆碱氧化酶。a栏:得自菌株PAMCOD的蛋白质提取物;b栏:得自菌株PAM的蛋白质提取物;c栏:纯化了的胆碱氧化酶。
图4示出NaCl对生长的影响,它显示了在0.4M NaCl的存在下,聚球蓝细菌菌株PAM(○)和PAMCOD(●)的生长情况。为了对比,还给出了在不含NaCl的培养基上培养的聚球蓝细菌菌株PAM(Δ)和PAMCOD(▲)的生长情况。
图5示出山梨醇对生长的影响,它显示了在0.8M山梨醇的存在下,聚球蓝细菌菌株PAM(○)和PAMCOD(●)的生长情况。为了对比,还给出了在不含山梨醇的培养基上培养的聚球蓝细菌菌株PAM(Δ)和PAMCOD(▲)的生长情况。
图6示出NaCl对叶绿素含量的影响,它显示了在0.4M NaCl的存在下,聚球蓝细菌菌株PAM(○)和PAMCOD(●)的叶绿素含量。
图7示出山梨醇对叶绿素含量的影响,它显示了在0.8M山梨醇的存在下,聚球蓝细菌菌株PAM(○)和PAMCOD(●)的叶绿素含量。
图8示出NaCl对光合活性的影响,它显示了在0.4M NaCl的存在下,从聚球蓝细菌菌株PAM(○)和PAMCOD(●)放出的氧量。
图9示出codA基因的限制酶图的示意图。
图10示出用于转化拟南芥属的双元载体质粒pGAH/cod A的结构示意图。
图11示出对于拟南芥属的野生型和转化体植物的可溶性部分中胆碱氧化酶的Western印迹分析(电泳照片)。1栏:得自商品化球形节杆菌的胆碱氧化酶(Sigma Chemical Co.St.Louis,MO,USA);2栏:
野生型植物的可溶性部分;3栏:转化体植物的可溶性部分。
图12示出NaCl对拟南芥属生长的影响。它显示在60mM NaCl存在下的野生型(A)和转化体C1-0(B)植物(显示有机体形态的照片)。
图13示出山梨醇对拟南芥属生长的影响。它显示在100、200和400mM山梨醇存在下的野生型(W)和转化体(T)植物(显示有机体形态的照片)。
图14示出盐作用对野生型和转化体植物(拟南芥属)叶子中光合作用系统II的影响。○:在光亮条件下温育的野生型植物;●:在光亮条件下温育的转化体植物;Δ:在暗处温育的野生型植物;▲:在暗处温育的转化体植物。每组数据表示标准偏差为±5%的三次试验的平均值。
图15示出用于转化稻的两种嵌合codA基因即35SINTPcodA和35SINcodA的结构。
图16示出的NMR谱图表示甜菜碱在野生型株、不表达codA基因的转化体(A)和表达codA基因的转化体(B)的稻类植物中的积累。图中:GB和Ch分别表示相应于甜菜碱和胆碱的峰。
图17示出盐作用对野生型和转化体稻类植物的光合系统II活性的影响。
本发明的最佳实施方案
本发明中所用编码胆碱氧化酶的基因是这种基因:它编码能在一步反应中将胆碱转化成甜菜碱的蛋白质,它可得自革兰氏阳性土壤细菌节杆菌属。例如,它可优选得自球形节杆菌和滋养节杆菌(Arthrobacterpascens),特别是球形节杆菌。
本发明人成功地克隆化得自球形节杆菌、编码胆碱氧化酶的codA基因并测定了它的核苷酸序列。该codA基因含有1641bp的开放读框,它编码547个氨基酸。codA基因的核苷酸序列和氨基酸序列如序列表中的SEQ ID No.1所示。
植物可用这种与合适的载体结合的胆碱氧化酶-编码基因转化。于是,通过在这些载体中引入合适的启动子或表达特性的序列,可在植物中表达该基因。
具有由编码序列表中SEQ ID No.1的氨基酸的核苷酸序列的添加、缺失或取代而产生的核苷酸序列的任意基因或其一部分可用作本发明的基因,只要它能编码显示胆碱氧化酶活性的多肽。
依本发明的方法,可赋与从蓝细菌至高等植物的大量植物以耐盐性和/或耐渗透性。蓝细菌被广泛地用作高等植物的有机体模型,因为它们与高等植物具有大致相同的光合机制,且它们易于在短时间内转化而给出结果。一些转化体型蓝细菌容易在其细胞中整合外源DNA而引起有效的重组。这类蓝细菌包括聚球蓝细菌PCC7942、聚球蓝细菌PCC6301(ATCC27144)和集胞蓝细菌PCC6803(ATCC27184)(Protein,Nucleic Acid,Enzyme,Vol.35,No.14,pp.2542-2551,1991;Crit.Rev.Microbiol.Vol.13,No.1,pp.111-132,1985)。
高等植物包括双子叶植物和单子叶植物。下述实施例中,高度耐盐性和/或耐渗透性植物可得自作为双子叶植物的芥属植物,但它不是限制性的,也可以用其它科和属的双子叶植物。本发明的方法也适合于单子叶植物。已发现原来缺乏甜菜碱合成能力的单子叶植物稻类可获得这种能力,于是用依本发明的方法转化后可获得耐盐性。
可根据待转化的植物性质来恰当地选择有待与编码胆碱氧化酶的基因结合的载体和转化方法,以及选择转化体植物原料。
例如,如pUC303的质粒可用于蓝细菌。这样,可通过插入这些质粒的抗生素抗性基因来选择具有所需性能的转化体。本发明通过用得自球形节杆菌的编码胆碱氧化酶的codA基因来转化蓝细菌聚球蓝细菌PCC7942,从而成功地获得可稳定地显示耐盐性和/或耐渗透性的植物。
如果将用codA基因转化的聚球蓝细菌PCC 7942置于补充氯化胆碱的培养基上培养,则发现聚球蓝细菌吸收了外源性供给的胆碱并将其转化为甜菜碱。鉴于该报道,即在数种耐盐性细菌中由盐作用引起胆碱迁移,导致积累更高含量的甜菜碱(Kaenjak,A.et al.,J.Bacteriol.175:2400-2406,1993),通过用不同浓度的NaCl处理由本发明产生的聚球蓝细菌转化体,测定盐作用对甜菜碱积聚的影响。但是,并未明显观察到NaCl浓度对甜菜碱积聚的影响,表明聚球蓝细菌中吸收胆碱用的转运蛋白并非专一性地由盐作用引起的。
据报道,甜菜碱不但起渗透防护剂作用,还在光自养生物中起重要的保护光合机制作用(Murata,N.et al,FEBS Lett.296:187-189,1992)。将依本发明转化的聚球蓝细菌在高浓度NaCl或山梨醇的存在下培养以检验其生长情况、叶绿素含量和光合活性。结果发现,在高浓度的盐或山梨醇存在下,聚球蓝细菌转化体生长良好,叶绿素含量和光合活性也显示类似的结果,而对照物非转化体中的生长情况、叶绿素含量和光合活性均受到抑制。这些结果说明,依本发明的方法用编码胆碱氧化酶的基因转化的聚球蓝细菌被赋与良好的耐盐性和耐渗透性。
双子叶植物可通过引入基因的技术用原生质体或组织的一部分进行转化。至于应用组织片段的基因引入,可采用得自土壤杆菌属(Agrobacterium)的Ti质粒。可以用带原生质体的土壤杆菌来感染有愈伤组织的植物组织片段,其中的原生质体中整合有编码胆碱氧化酶的基因;通过对抗生素如卡那霉素的抗性进行选择,然后在茎干中分化而得转化体植物。
在本发明中,如下所示通过用编码胆碱氧化酶的基因来转化芥属植物拟南芥而得到耐盐性和/或耐渗透性植物。
制备携带codA基因的双元载体质粒pGAH-codA,并整合到携带Ti质粒的复盆子土壤杆菌(Agrobacterium tumefaciens)EHA101中。用所得整合有codA基因的土壤杆菌EHA101(pGAH/codA)感染拟南芥的下胚轴愈伤组织,然后形成枝,通过对卡那霉素和潮霉素的抗性进行选择,以产生根并形成籽。将得自所述杂合T2籽的植物进行自花受精而得纯合的T3个体,将其播种后形成转化体植物。这些转化体植物表明,胆碱氧化酶已被转运至叶绿体。即使在高浓度的氯化钠或山梨醇存在下,这种转化体植物也生长良好。
可用在质粒pUC119上制备的两种嵌合codA基因转化单子叶植物稻(稻属sativa L.cv.Nippon bare),这些基因在花椰菜花叶病毒35S启动子转录控制下翻译后被定位于胞质溶胶或质体上。这两种嵌合基因在5′非翻译序列中包含得自稻的内含子以增强表达。
可用如下方法产生转化体稻,即可这样获得转化体植物:用基因枪装置将所述嵌合codA基因与选择标记即潮霉素抗性基因一起引入得自稻籽盾片愈伤组织的悬浮培养细胞,然后基于对抗生素的抗性选择已转化的愈伤组织,并将它们再分化成植物。
虽然野生型稻缺乏合成甜菜碱的能力,但用本发明的方法转化过的稻获得了合成甜菜碱的能力。表达codA基因的转化体稻与未转化的植物生长得同样好,在耕作和溶液培养这两种条件下未显示任何异常。由此可见,在甜菜碱的合成中形成的产物过氧化氢已于细胞中被有效地解毒。
此外,培养于含NaCl的水中的转化体的耐盐性试验表明,转化体中光合活性的抑制比在野生型中观测到的慢。这是首例通过基因工程方法使稻获得合成甜菜碱的能力。
这些结果表明,用携带编码胆碱氧化酶的基因的重组载体转化的各种植物具有极好的耐盐性。
依本发明,可获得高度耐恶劣环境的耐盐性和/或耐渗透性转化体植物。可依本发明的方法赋与耐盐性和/或耐渗透性的植物范围很广,可以从蓝细菌到高等植物。特别是,本发明系首例从包括大部分主要作物在内的单子叶植物而得到耐盐性和/或耐渗透性植物,并有望在很广的范围内应用。
下述实施例进一步详细地阐述本发明,但并不是要限制本发明的范围。
实施例
实施例1:用codA基因转化蓝细菌聚球蓝细菌PCC7942
(1)codA基因的克隆化
依the Abstracts of Oral Reports in the abstracts,the 34th annualmeeting of the Japanese Society of Plant Physiologists,1994中描述的方法从球形节杆菌分离胆碱氧化酶基因。简言之,1)用溴化氰分裂胆碱氧化酶,2)测定合适的片段的N端氨基酸序列,3)从所述部分氨基酸序列中选择合适的部分来合成其对应的寡核苷酸,4)利用这些寡核苷酸作引物通过PCR(聚合酶链式反应)扩增胆碱氧化酶基因的部分序列,5)将胆碱氧化酶基因已扩增的部分序列用作探针来筛选球形节杆菌的基因组DNA文库。
将如此得到的阳性克隆亚克隆至质粒pBluescript(SK+)(Stratagene)以分离阳性克隆,再对阳性克隆进行Southern印迹分析。把一个与所述探针杂交的3.6kbp XbaI-XhoI片段亚克隆至pBluescript中并用限制酶作图。测定从第一个SalI位点至XhoI位点的区域(约2.5kbp)的核苷酸序列。
结果表明,胆碱氧化酶基因含有编码547个氨基酸残基的多肽的1641bp开放读框。编码胆碱氧化酶的基因的氨基酸序列和核苷酸序列如序列表中的SEQ ID No.1所示。
(2)用codA基因转化聚球蓝细菌PCC7942
将携带codA基因的质粒pBluescript用BstEII(离翻译起始的位置为-40)限制酶和SmaI(终止密码子的下游)限制酶进行消化。用Klenow片段(Takara,Tokyo,Japan)补平BstEII粘端。把含codA基因的编码区和推定的核糖体结合位点的平端片段插入质粒pAM1044的SmaI位点。由限制酶切分析确证基因的正确取向,认为是在pAM1044的conII启动子的控制下表达的。conII启动子是大肠杆菌的启动子的共有序列,它含有碱基序列TTGGACA(-35)和TATAAT(-10)。
采用Elhai et al.的方法,用质粒pAM1044和含codA基因的质粒来转化聚球蓝细菌PCC7942。将所得转化体称为PAMCOD株。只用pAM1044转化的聚球蓝细菌PCC7942用作对照物并被称为PAM株。
在含30μg/ml壮观霉素的BG11琼脂板上选择转化体。将单个菌落接种到含壮观霉素的新鲜BG11板上数次之后,用图2A中指示的引物通过PCR(聚合酶链式反应)确证壮观霉素抗性基因和codA基因已完全插入所有染色体拷贝中。用引物1和2的组合通过PCR证实壮观霉素抗性基因和codA基因已完全插入聚球蓝细菌的染色体中。
实施例2:对插入转化体中的基因的确证
将得自聚球蓝细菌PCC7942的野生型株、PAM株和PAMCOD株的DNAs用作PCR的模板,并用SDS-PAGE分析扩增后的产物,结果如图2B中所示。
对得自野生型株的DNA进行的PCR显示约400bp的扩增产物(图2B,b栏)。得自PAM株的DNA用作模板时,则出现约2.4kb的条带,表示pAM1044插入染色体中。发现野生型株缺少约400bp的条带,证实天然染色体全部被PAM株内的突变染色体置换了。
得自PAMCOD株的DNA用作模板时,未观察到相应于野生型染色体的条带(图2B,c栏)。但是,约4.1kb的预期条带也未被扩增,可能是由于插入片段体积大和codA序列中的GC含量高的缘故。因此,将相当于codA基因的编码区的引物3(图2A)与引物1组合应用。约2.6kb的预期条带被扩增了(图2B,d栏),表明PAMCOD株的染色体内存在codA基因。
实施例3:在聚球蓝细菌PAMCOD株内表达codA基因
通过Western印迹分析检验实施例1中所得PAMCOD株内codA基因的表达,其中应用抗纯化后胆碱氧化酶的多克隆抗血清。结果示于图3。在位置60kDa处检出得自PAMCOD株(a栏)和纯化后的胆碱氧化酶(c栏)的蛋白质提取物中有信号。而在得自PAM株(b栏)的蛋白质提取物中未检出这种信号。结果证实,在聚球蓝细菌PCC7942内,于conII启动子的控制下表达了codA基因。
实施例4:细胞内甜菜碱浓度的分析
转化后的细胞生长于添加5mM氯化胆碱的一升BG11培养基中。加入不同浓度的NaCl构成盐作用。在25℃下用1M H2SO4处理收获的细胞达20小时,并利用高碘酸盐沉淀技术(Wall,J.S.etal.,Analyt.Chem.32:870-874,1960)从混合物中回收甜菜碱。将甜菜碱高碘酸盐溶于1ml甲醇-d4(Wako Pure Chemical Industries,Osaka,Japan),其中含有作内标的2mM 2-甲基-2-丙醇(Wako PureChemical Industries)。该溶液被转入NMR管,并用Bruker AMX360Wb测定1H-NMR光谱。通过与标准曲线比较积分峰来定量甜菜碱。
基于从负染细胞的电子显微照片估测的细胞体积,测定PAMCOD株细胞内的甜菜碱浓度。单个细胞的细胞质为圆柱形,它长2.14μm、直径为0.82μm,且估测的细胞体积约为1.13μm3。
下列表1示出随着培养基中NaCl浓度的增大,细胞中甜菜碱浓度的变化情况。在没有codA基因的PAM株内未检测出甚至微量的甜菜碱。PAMCOD株细胞内的甜菜碱浓度范围为60-90mM。NaCl浓度未显著影响PAMCOD株细胞内甜菜碱的积聚。
表1NaCl(M) PAM(mM) PAMCOD(mM)0 0 67±30.2 0 73±40.3 0 86±2
实施例5:聚球蓝细菌PAMCOD株对盐作用和渗透作用的耐受性
通过测定细胞生长情况、叶绿素含量和光合活性来估测细胞对盐作用和渗透作用的耐受性。聚球蓝细胞PAM株和PAMCOD株的细胞预先在添加有1mM氯化胆碱的BG11培养基中于30℃培养3天,然后将培养物转入添加有1mM氯化胆碱、其中含0.4M NaCl或0.8M山梨醇的BG11培养基。利用730nm处的光密度监测细胞的生长。用Arnon et al.描述的方法(Biochim.Biophys,Acta.357:231-245,1974)测定叶绿素含量。用Clark型氧电极、以1mM1,4-苯醌和1mM K3Fe(CN)6为电子受体通过监测氧浓度而测定光合的氧放出量。以在不含NaCl的培养基上培养的同样细胞为对照物。
在NaCl存在下细胞生长试验的结果如图4所示,而在山梨醇存在下细胞生长试验的结果示于图5。PAM株的生长受到高的盐作用和渗透作用的抑制,但PAMCOD株却能在这些条件下生长。
在NaCl存在下叶绿素含量测试结果示于图6,而在山梨醇存在下叶绿素含量测试结果如图7所示。这些测试结果类似于细胞生长试验的结果。用高浓度的盐处理后的PAM株内叶绿素含量逐渐降低,而用0.8M山梨醇处理过的PAM株内叶绿素的含量迅速降低;反之,即使用盐或山梨醇处理后,PAMCOD株也能继续生长。
在NaCl存在下光合活性的测试结果如图8中所示。PAM株的光合活性严重地受盐作用的抑制。反之,PAMCOD株细胞的光合活性在盐处理的初始阶段暂时受抑制,但随后恢复并继续升高。在山梨醇存在下测得类似的光合活性结果。有趣的是,用0.8M山梨醇处理PAMCOD株细胞时,未观察到光合活性的暂时降低。
实施例6:制备携带codA基因的双元载体质粒
用5′CTGTCTAGATGTAATTAACAATGGCT3′和5′CCACATATGCATGCATTGCACTCT3′作引物,通过PCR对得自烟草(Nicotiana sylvestris)的rbcS(核酮糖-1,5-二磷酸羧化酶小亚基)转运信号XbaI-NdeI片段(约200bp)进行扩增以引入XbaI位点和NdeI位点。
然后,用5′AACCATATGCACATCGACAACATC3′和5′GCTCCATCCAGCGGTCCAGC3′作引物,通过PCR对codA基因的N端-BamHI片段(约100bp)进行扩增以引入NdeI位点。用限制酶制备codA基因的BamHI-SmaI片段(约1.6kbp)。进一步地,用5′GAAACAGTCCTGCTTCCACAC3′和5′GCG AG C TCTGCCTACACCGCCAT3′作引物通过PCR对codA基因的SmaI-C端片段(约80bp)进行扩增以引入SacI位点。
用这些片段置换双元载体质粒pBI221中的GUS(β-葡糖醛酸酶)基因。
codA基因的限制酶图示于图9。
将含35S启动子和花椰菜花叶病毒的NOS(胭脂氨酸合酶(nopalin synthase))终止子的HindIII-EcoRI片段引入双元载体质粒pGAH以制备质粒pGAH/codA(图10)。该质粒含抗卡那霉素和潮霉素的基因。
实施例7:将双元载体质粒引入土壤杆菌
将携带Ti质粒的复盆子土壤杆菌EHA101与实施例6中制得的双元载体质粒pGAH/codA混合,然后冷冻并融化,在含有四环素和卡那霉素的LB板上筛选。将所得其中整合了codA基因的土壤杆菌称为EHA101(pGAH/codA)。
实施例8:拟南芥的转化
让拟南芥WS株发芽以制备下胚轴片段。将该下胚轴用B5培养基(ICN Biochemicals)(pH5.7),该培养基中含0.05mg/l的细胞分裂素(Wako Pure Chemical Industries)和0.5mg/l的2,4-D(Wako Pure Chemical Industries)进行愈伤组织化,以形成下胚轴愈伤组织。
然后,用实施例7中制备的含codA的土壤杆菌EHA101(pGAH/codA)感染该愈伤组织并共培养。用含250mg/l万古霉素、500mg/l羧苄青霉素和200mg/l头孢氨噻的B5培养基对土壤杆菌解毒之后,将培养物转入分化培养基(含25mg/l卡那霉素和15mg/l潮霉素的B5培养基)以形成分枝。然后,选择抗卡那霉素和潮霉素的枝以引入根并形成籽。只对所得T2籽的染色体之一进行杂合的转化。
然后,使得自T2籽的植物自花受精并通过卡那霉素和潮霉素选择而得纯合的T3籽。
让野生型株和转化体株的植物于22℃下在含0.1%HYPONEX(Hyponex Corporation,Marysville,OH,USA)的培养基(pH5.2)中生长30天,培养基基于水或由蛭石和珍珠岩组成的土壤,除非另有说明,一天的16小时照明度为75μmol·m-2·S-1而其余8小时是在暗室中;然后用于实验。
实施例9:对已表达的胆碱氧化酶的免疫研究
依本发明人在文献中描述过的方法(Deshniumn,P.etal.,Plant Mol.Biol.29:897-907,1995)产生抗胆碱氧化酶的抗体。
将拟南芥的野生型和转化体株20天龄植物叶在0℃下置于微量离心机中旋转摩擦,匀浆物在10,000xg下离心10分钟以制备可溶性级分。用SDS-PAGE分离上清液的可溶性蛋白质后转入尼龙膜(Immobilon PVDF;Millipore,Bedford,MA,USA)。将膜与抗胆碱氧化酶的抗体一起温育,再用由生物素化次级抗体、亲和素和生物素化辣根过氧化物酶(ABC Kit;Vectastain,Burlingane,CA,USA)组成的系统检测。
Western印迹分析结果示于图11。验明存在相应于胆碱氧化酶的64kDa免疫应答蛋白。还观察到少量相应于胆碱氧化酶前体的70kDa蛋白质和rbcS转运肽。这些结果表明,codA基因在染色体中已被正确地整合和表达,且已表达的前体被加工成成熟蛋白质。
然后,依文献中所述方法(Mustardy,L.et al.,Plant Physiol.94:334-340,1990)用抗胆碱氧化酶的抗体检测了已在植物中表达的胆碱氧化酶的定位。用1%戊二醛的0.1M磷酸钠缓冲液(pH7.2)固定植物的小片嫩叶达1小时。用相同的缓冲液漂洗后,样品用乙醇脱水,置于Lowicryl K4M树脂(TAAB LaboratoriesEquipment Ltd.Berkshire,U.K.)内。按文献中所述方法(Mustardy et al.,supra)进行免疫金标记。
结果发现,已表达的胆碱氧化酶被定位于叶绿体的基质内,表明胆碱氧化酶已被转运至叶绿体中。
实施例10:转化体植物中甜菜碱和叶绿素含量的测定
通过测定季铵化合物的NMR谱(Wall,J.et al.,Analyt.Chem.32:870-874,1960)而计算植物叶中甜菜碱的含量。在液氮中用陶瓷磨机(motor)将5g野生型株和转化体植物的叶子磨成粉,使粉末悬浮于25ml 1.0M H2SO4并在25℃下保温2小时。除去不溶性物质后,在1000xg下离心10分钟以回收上清液。将上清液与10ml KI-I2溶液混合并在0℃下保温2小时。在1000xg下离心30分钟回收甜菜碱和胆碱的高碘化物加合物,再溶于0.5mlCD4OH(Wako Pure Chemical Industries)(含有作内标的0.5mM 2-甲基-2-丙醇(Wako Pure Chemical Industries))而测定1HNMR谱。观测到对应于甜菜碱和胆碱的两个主要峰,其中的甜菜碱积分峰用于测定其浓度。
通过下列方法测定叶内叶绿素的含量:在液氮中用陶瓷磨机将叶(1g)磨成粉,让粉末悬浮于10ml丙酮∶水(4∶1,v/v)。保温30分钟后,除去不溶性物质,对上清液进行分光光度测定(Arnon,D.I.Plant Physiol.24:1-15,1949)。
结果发现,转化体植物中含甜菜碱和胆碱,而野生型株内只测出胆碱。甜菜碱含量为1.0μmol/g鲜叶,叶绿素含量为0.3μmol/g鲜叶。
实施例11:拟南芥转化体对盐作用和渗透作用的耐受性
(1)对盐作用的耐受性
将得自实施例8的T3籽接种于用0.5%gellan gum凝胶化的Murashige & Skoog′s培养基上,比较子叶的发芽、生根和生长。在不含NaCl的培养基上,野生型株和转化体植物之间未发现任何差异。但是,在含60mM氯化钠的培养基上,与长势较差的野生型株相比,转化体植物之一C1-0相对地长势良好而显示出耐盐性(图12)。
在含100mM氯化钠的培养基上,野生型株在发芽10天后便停止生长,且它的叶子变白。然而,转化体植物继续生长同时保持绿色。尤其是转化体植物的根长势显著优于野生型株的根。在不含100mM氯化钠的对照试验中,野生型株和转化体株植物的长势相当,证实转化体植物已获得在盐作用条件下生长的能力。
(2)对渗透作用的耐受性
对野生型株和转化体植物的籽灭菌后接种于含100、200和400mM山梨醇的半固态培养基上。将培养物置于22℃下的恒温箱中,一天中的16小时保持75μmol/m2/秒的照明度,而其余8小时是在暗室中;并定期观察。第15天的状态示于图13(左边的W表示野生型株而右边的T表示转化体植物)。当山梨醇浓度为100mM时,一些野生型株未发芽,或者即使它们发芽了,其叶子也变白。然而,转化体植物继续生长并保持绿色。在200mM的浓度下,两种株的生长均受抑制,但转化体植物的受抑制程度低于野生型株,尤其是转化体植物根的长势显著优于野生型株。在400mM的浓度下,野生型株不发芽,而转化体植物也未发芽,或者即使它们发芽了,也极少生长。
实施例12:在盐作用下转化体植物的光合活性
通过监测叶绿素的荧光来测定盐作用对成熟叶子光合系统II活性的影响。
将生长于对照培养基上的野生型株和转化体株植物转至含400mM氯化钠的HYPONEX培养基,并在上述光亮或黑暗条件下温育。在一定的时间后,从植物上摘下叶子,采用脉冲强度调制荧光计(PAM-2000;Walts,Effeltrich,Germany)测定光合系统II的效率并以叶绿素荧光变量与叶绿素荧光极大值的比(Fv/Fm)表示(Annu.Rev.Plant Physiol.Plant Mol.Biol.42:313-349.1991)。
结果示于图14。在光亮条件下温育2天后,野生型株几乎丧失光合系统II活性,而转化体植物维持其光合系统II活性初始值的50%。在黑暗条件下,盐作用引起的失活作用要缓和得多,但转化体植物的光合系统II活性对盐作用的耐受性比野生型株更高。当植物被转至含200mM氯化钠的培养基时,光合系统II活性的降低比在含400mM氯化钠的培养基上时所观察到的要缓和得多,但转化体植物对盐作用的耐受性也比野生型株更高。
实施例13:用于转化稻的嵌合codA基因的制备
按实施例6中所述方法,在花椰菜花叶病毒35S启动子的转录控制下翻译得自球形节杆菌的胆碱氧化酶基因(codA)之后,于质粒pUC119上制得分别定位于胞质溶胶和质体上的两种嵌合codA基因(分别称为35SIN cod A和35SINTPcodA)(参见图15)。考虑到要求存在内含子以高表达稻内基因(例如参见:Tanaka,A.et.al.Nucleic Acids Res.18:6767-6770,1990),将稻的超氧化物歧化酶基因中5′非翻译序列内的内含子(SodCc2:Sakamoto,A.et al.,FEBS Lett.358:62-66,1995)引入这二种嵌合基因。进一步地,将得自豌豆rbc S转运肽的DNA序列(Coruzz,G.et al.,EMBO J 3:1671-1679,1984)加入35SINTPcodA,以将codA蛋白质转入叶绿体。
实施例14:稻的转化
将实施例13中制备的两种嵌合codA基因中的每种和潮霉素抗性基因这种选择标记一起用基因枪装置引入得自稻籽的盾片愈伤组织的悬浮培养细胞。基于对抗生素的抗性选择已转化的愈伤组织并再分化成植物。对已转化的愈伤组织或显示潮霉素抗性的已转化/再分化了的个体进行聚合酶链式反应(PCR),用Northern印迹技术估测该codA基因整合和转录入核基因组的情况,并对每个codA基因选择80-100或更多个转化体。
实施例15:codA基因在转化体稻内的表达分析
利用Western印迹技术筛选实施例14中获得的转化体而得在蛋白质水平表达codA基因的转化体稻(本代),最终包括6个携带质体定位化基因的个体和10个携带胞质溶胶定位化基因的个体。
稻缺乏内在胆碱氧化酶活性,但从转化体的叶或根制得的可溶性部分显示出胆碱氧化酶活性。与预料的相反,尽管是用相同的表达启动子,但发现所有的质体型转化体个体表达胆碱氧化酶蛋白质的量比胞质溶胶型更少。
当进一步用Northern印迹技术检验codA基因的表达时,未发现在转录水平表达的两种基因的量有什么明显差别。在用逆转录PCR检验内含子的加工时,从转录自质体型基因的mRNA检测出大量含不同的3′-接受位点的剪接变体,它不可能正常翻译成蛋白质。这启示,用质体型基因转化的植物表达的蛋白质量少可能是由于mRNA前体异常加工所致。此现象可能与下列事实有关,即编码用于胆碱氧化酶的质体导向的转运肽的序列是得自双子叶植物(豌豆rbcS基因)。因此,易于预测:如果编码转运肽的序列得自如稻rbcS的单子叶植物,则稻叶绿体内codA的表达会更为有效,且所得转化体稻将会更能耐盐作用。
实施例16:在转化体稻内生物合成甜菜碱
用质子NMR检测表达胆碱氧化酶的转化体组织内甜菜碱的积聚。图16示出野生型株、不表达codA基因的转化体(图16A)和表达codA基因的转化体(图16B)三者的NMR结果。
表达胆碱氧化酶的转化体生物合成甜菜碱,甜菜碱积聚的量与由Western印迹技术测定的胆碱氧化酶的量呈正比关系。叶内积聚的甜菜碱多于根内的测定值,且在高水平表达codA基因的个体内达4μmol/g鲜叶。这是首例通过基因工程方法使稻获得合成甜菜碱的能力。
实施例17:估测转化体稻的耐盐性
在耕作和溶液培养这两种条件下,表达codA基因的转化体稻与非转化体(野生型)生长得同样好,未显示什么明显异常。这表明,甜菜碱生物合成中形成的副产物过氧化氢在细胞中已被有效地解毒。
然后,在含氯化钠的溶液培养条件下,使可在蛋白质水平表达codA基因、有酶活性和甜菜碱生产能力的转化体生长。用叶绿素荧光分析估测Na盐对光合活性的影响并与非转化体(野生型)的结果比较。将转化体稻和非转化体稻置于含100mM和10mM氯化钠的HYPONEX水溶液之后,测定叶绿素荧光随时间的关系,发现转化体中光合活性的抑制减慢了(图17)。因此,发现转化体更能耐盐环境。〔序列表〕SEQ ID No:1序列长度:2400序列类型:核酸链型:双链拓扑结构:线型分子类型:DNA序列特征特征键:缠结肽位置:361..2002序列描述:GGGAATATCC GTCGTCGTAG ACGAGCCCTT CGGCCCGTGT AAAGGTGGAG ACCTTCCACA 60CCGAGGACGA GGCCGTCGCG ACCGCCAACG ACACCAACTA CGGGCTGTCC GGCGCGGTCC 120TGGACCCAGG ACGCCGGCAA GACGCAGCGC GTGGCCGGCC GGCTGCGACA CGGCACCGTC 180TGGATCAACG ACTTCCACCC CTACCTCCCA CAGACCGAGT GGGGCGGCTT CGGCCAGTCC 240GGCGTCGGCC GCGAACTCGG CCCGACCGGC CTGGCCGAGT ACCAGGAGGC CAAGCACATC 300TACCAGAACA CCAGCCCGCA GGTCACCGGC TGGTTCGCTG ACCACGGCAA GGAGAACTAG 360ATG CAC ATC GAC AAC ATC GAG AAC CTG AGC GAC AGG GAG TTC GAC TAC 408Met His Ile Asp Asn Ile Glu Asn Leu Ser Asp Arg Glu Phe Asp Tyr1 5 10 15ATC GTC GTC GGC GGC GGG TCC GCC GGG GCC GCC GTC GCC GCC CGG CTG 456Ile Val Val Gly Gly Gly Ser Ala Gly Ala Ala Val Ala Ala Arg Leu
20 25 30AGC GAG GAT CCC GCA GTG AGC GTG GCG CTG GTG GAG GCC GGC CCG GAT 504Ser Glu Asp Pro Ala Val Ser Val Ala Leu Val Glu Ala Gly Pro Asp
35 40 45GAC CGC GGC GTG CCC GAG GTG CTG CAG CTG GAC CGC TGG ATG GAG CTG 552Asp Arg Gly Val Pro Glu Val Leu Gln Leu Asp Arg Trp Met Glu Leu
50 55 60CTG GAA TCG GGC TAC GAC TGG GAC TAC CCG ATC GAG CCG CAG GAG AAC 600Leu Glu Ser Gly Tyr Asp Trp Asp Tyr Pro Ile Glu Pro Gln Glu Asn65 70 75 80GGC AAC TCC TTC ATG CGC CAT GCC CGT GCC AAG GTC ATG GGC GGC TGC 648Gly Asn Ser Phe Met Arg His Ala Arg Ala Lys Val Met Gly Gly Cys
85 90 95TCC AGC CAC AAC TCC TGC ATC GCC TTC TGG GCC CCG CGC GAG GAC CTG 696Ser Ser His Asn Ser Cys Ile Ala Phe Trp Ala Pro Arg Glu Asp Leu
100 105 110GAC GAG TGG GAG GCC AAG TAC GGC GCC ACC GGC TGG AAC GCC GAG GCG 744Asp Glu Trp Glu Ala Lys Tyr Gly Ala Thr Gly Trp Asn Ala Glu Ala
115 120 125GCC TGG CCG CTG TAC AAG CGG CTG GAA ACC AAC GAG GAC GCG GGC CCG 792Ala Trp Pro Leu Tyr Lys Arg Leu Glu Thr Asn Glu Asp Ala Gly Pro130 135 140GAC GCG CCG CAC CAC GGG GAC TCC GGC CCC GTG CAC CTG ATG AAC GTG 840Asp Ala Pro His His Gly Asp Ser Gly Pro Val His Leu Met Asn Val145 150 155 160CCC CCG AAG GAC CCG ACC GGC GTC GCG CTC CTG GAC GCC TGC GAG CAG 888Pro Pro Lys Asp Pro Thr Gly Val Ala Leu Leu Asp Ala Cys Glu Gln
165 170 175GCC GGC ATC CCG CGC GCG AAG TTC AAC ACC GGC ACC ACC GTG GTC AAC 936Ala Gly Ile Pro Arg Ala Lys Phe Asn Thr Gly Thr Thr Val Val Asn
180 185 190GGC GCC AAC TTC TTC CAG ATC AAC CGG CGC GCG GAC GGC ACC CGC TCC 984Gly Ala Asn Phe Phe Gln Ile Asn Arg Arg Ala Asp Gly Thr Arg Ser
195 200 205TCC AGC TCG GTC TCC TAC ATC CAC CCG ATC GTC GAG CAG GAG AAC TTC 1032Ser Ser Ser Val Ser Tyr Ile His Pro Ile Val Glu Gln Glu Asn Phe210 215 220ACC CTG CTA ACC GGC CTG CGC GCC CGC CAG CTG GTG TTC GAC GCG GAC 1080Thr Leu Leu Thr Gly Leu Arg Ala Arg Gln Leu Val Phe Asp Ala Asp225 230 235 240AGG CGC TGC ACC GGC GTC GAC ATC GTG GAC TCC GCC TTC GGC CGC ACC 1128Arg Arg Cys Thr Gly Val Asp Ile Val Asp Ser Ala Phe Gly Arg Thr
245 250 255CAT CGG CTG ACG GCG CGC AAT GAA GTC GTG CTC TCC ACC GGC GCG ATC 1176His Arg Leu Thr Ala Arg Asn Glu Val Val Leu Ser Thr Gly Ala Ile
260 265 270GAT ACG CCG AAG CTG TTG ATG CTC TCC GGA ATC GGC CCC GCC GCC CAC 1224Asp Thr Pro Lys Leu Leu Met Leu Ser Gly Ile Gly Pro Ala Ala His
275 280 285CTC GCC GAG CAC GGC ATC GAG GTC CTT GGT GGA CTC CCC CGG CGT GGG 1272Leu Ala Glu His Gly Ile Glu Val Leu Gly Gly Leu Pro Arg Arg Gly290 295 300CGA GCA CCT GCA GGA CCA CCC GGA AGG CGT GGT GCA GTT CGA GGC CAA 1320Arg Ala Pro Ala Gly Pro Pro Gly Arg Arg Gly Ala Val Arg Gly Gln305 310 315 320GCA GCC CAT GGT CGC CGA GTC CAC GCA GTG GTG GGA GAT CGG CAT CTT 1368Ala Ala His Gly Arg Arg Val His Ala Val Val Gly Asp Arg His Leu
325 330 335CAC CCC CAC CGA GGA CGG CCT GGA CCG CCC CGA CCT GAT GAT GCA CTA 1416His Pro His Arg Gly Arg Pro Gly Pro Pro Arg Pro Asp Asp Ala Leu
340 345 350CGG CTC CGT GCC GTT CGA CAT GAA CAC CCT GCG GCA CGG CTA CCC CAC 1464Arg Leu Arg Ala Val Arg His Glu His Pro Ala Ala Arg Leu Pro His
355 360 365CAC GGA GAA CGG GCT TCA GCC TCA CCC CGA ACG TCA CGC ACG CCC GCT 1512His Gly Glu Arg Ala Ser Ala Ser Pro Arg Thr Ser Arg Thr Pro Ala370 375 380CCC GCG GCA CTG TCC GGC TGC GCA GCC GCG ACT TCC GCG ATA AGC CCA 1560Pro Ala Ala Leu Ser Gly Cys Ala Ala Ala Thr Ser Ala Ile Ser Pro385 390 395 400TGG TCG ACC CGC GCT ACT TCA CCG ACC CAG AAG GGC CAT GAC ATG CGC 1608Trp Ser Thr Arg Ala Thr Ser Pro Thr Gln Lys Gly His Asp Met Arg
405 410 415GTC ATG GTC GCC GGC ATC CGC AAG GCC CGC GAA ATC GCC GCC CAG CCC 1656Val Met Val Ala Gly Ile Arg Lys Ala Arg Glu Ile Ala Ala Gln Pro
420 425 430GCC ATG GCG GAA TGG ACC GGC CGC GAG CTC TCC CCC GGC GTC GAG GCG 1704Ala Met Ala Glu Trp Thr Gly Arg Glu Leu Ser Pro Gly Val Glu Ala
435 440 445CAG ACC GAC GAG GAG CTG CAG GAC TAC ATC CGC AAG ACG CAC AAC ACC 1752Gln Thr Asp Glu Glu Leu Gln Asp Tyr Ile Arg Lys Thr His Asn Thr450 455 460GTC TAC CAC CCC GTG GGC ACC GTG CGC ATG GCC GCG GTC GAG GAC GAG 1800Val Tyr His Pro Val Gly Thr Val Arg Met Gly Ala Val Glu Asp Glu465 470 475 480ATG TCC CCG CTC GAC CCC GAG CTG CGG GTC AAG GGC GTC ACC GGT CTG 1848Met Ser Pro Leu Asp Pro Glu Leu Arg Val Lys Gly Val Thr Gly Leu
485 490 495CGC GTC GGC GAC GCC TCG GTC ATG CCC GAG CAC GTG ACC GTC AAC CCC 1896Arg Val Gly Asp Ala Ser Val Met Pro Glu His Val Thr Val Asn Pro
500 505 510AAC ATC ACC GTC ATG ATG ATC GGC GAG CGC TGC GCG GAC CTT ATC CGC 1944Asn Ile Thr Val Met Met Ile Gly Glu Arg Cys Ala Asp Leu Ile Arg
515 520 525TCC GCC CGC GCC GGT GAA ACA ACG ACG GCG GAC GCC GAG CTG AGC GCG 1992Ser Ala Arg Ala Gly Glu Thr Thr Thr Ala Asp Ala Glu Leu Ser Ala530 535 540GCC CTC GCC TAAGCGGGAG CGGCCAGCCG CGGGGCCTGT CCGGAACCAC CTGGCGGGCC 2051Ala Leu Ala545 547CCGCATGGGG CCGGACACAA TGCCGGTAAC TAAGGGTGCG GAAGCAGTCC TGCTTCCACA 2111CCCGCGTTTT GCACGCCCGG GCCGGCAACT GGCCCGGCCG GCTAAGCCGA AGGTCTTCCG 2171GGGGCGGGCC GGATCGCTGC GGGCAGTCCG TCGGCGAGCC GCTGCAGCGT GCCGGCGGTA 2231ATGGCGGTGT AGGCAGGGAT CGCGTCGGGG TAGATGTACT CGTTGCGGGC GTGCGCGCCG 2291TCGCCCACCG CGCCCAGGCC GCACAGGACC GGGATGCCGA GGGCGGAGAC GAAGTTGGCG 2351TCGCTGCCCC CGCCCACCGA GGCGGTTTCC AGCTCCCGGC CCTGCTCCA 2400
Claims (10)
1.产生耐盐性和/或耐渗透性植物的方法,它包括用携带编码胆碱氧化酶的基因的重组载体转化植物的步骤。
2.权利要求1的方法,其中编码胆碱氧化酶的基因得自土壤细菌节杆菌属。
3.权利要求1或2的方法,其中编码胆碱氧化酶的基因是编码序列表中SEQ ID No.1的氨基酸序列的碱基序列,或者是编码SEQ ID No.1的修饰氨基酸序列的核苷酸序列,其中的修饰氨基酸序列是通过添加和/或缺失一个或多个氨基酸序列和/或被其它氨基酸取代而产生的,只要该核苷酸序列能编码具有胆碱氧化酶活性的蛋白质即可。
4.权利要求1-3中任一项的方法,其中的耐盐性和/或耐渗透性植物是蓝细菌。
5.权利要求1-3中任一项的方法,其中的耐盐性和/或耐渗透性植物是高等植物。
6.权利要求5的方法,其中的高等植物是双子叶植物。
7.权利要求6的方法,其中的双子叶植物是芥属植物。
8.权利要求5的方法,其中的高等植物是单子叶植物。
9.权利要求8的方法,其中的单子叶植物是禾本科植物。
10.依权利要求1的方法产生的耐盐性和/或耐渗透性植物,或其具有相同特性的子代。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP106819/95 | 1995-03-27 | ||
JP106819/1995 | 1995-03-27 | ||
JP10681995 | 1995-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1182348A true CN1182348A (zh) | 1998-05-20 |
CN1167800C CN1167800C (zh) | 2004-09-22 |
Family
ID=14443421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB961935022A Expired - Fee Related CN1167800C (zh) | 1995-03-27 | 1996-03-27 | 产生耐渗透性植物的方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6281412B1 (zh) |
EP (1) | EP0818138B1 (zh) |
KR (1) | KR19980703382A (zh) |
CN (1) | CN1167800C (zh) |
AT (1) | ATE267260T1 (zh) |
AU (1) | AU709777B2 (zh) |
CA (1) | CA2216621A1 (zh) |
DE (1) | DE69632534T2 (zh) |
HK (1) | HK1018159A1 (zh) |
WO (1) | WO1996029857A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103200814A (zh) * | 2010-10-27 | 2013-07-10 | 韩国生命工学研究院 | 源于蓝细菌的耐盐性SyDBSP基因及其用途 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329574B1 (en) | 1990-01-22 | 2001-12-11 | Dekalb Genetics Corporation | High lysine fertile transgenic corn plants |
US6326527B1 (en) | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US5780709A (en) * | 1993-08-25 | 1998-07-14 | Dekalb Genetics Corporation | Transgenic maize with increased mannitol content |
US6118047A (en) | 1993-08-25 | 2000-09-12 | Dekalb Genetic Corporation | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
WO1997024026A1 (fr) * | 1995-12-28 | 1997-07-10 | Suntory Limited | Procede d'obtention par recombinaison de plantes insensibles a la temperature |
SE9604532D0 (sv) * | 1996-12-09 | 1996-12-09 | Leif Buelow | Transgenic plants having increased freezing tolerance |
ZA986308B (en) * | 1997-07-18 | 1999-11-24 | Pioneer Hi Bred Int | The induction of stress-related factors in plants. |
US6166291A (en) | 1997-07-18 | 2000-12-26 | Pioneer Hi-Bred International, Inc. | Production of pathogen resistant plants |
US7279619B2 (en) | 1998-01-22 | 2007-10-09 | National Research Council Of Canada | Methods and compositions for modifying levels of secondary metabolic compounds in plants |
JP2002502587A (ja) * | 1998-01-22 | 2002-01-29 | ナショナル、リサーチ、カウンシル、オブ、カナダ | 植物において二次代謝化合物のレベルを改変する方法および組成物 |
ATE528401T1 (de) * | 1998-08-04 | 2011-10-15 | Cropdesign Nv | Gene, welche an der toleranz gegenüber umweltstress beteiligt sind |
US6063607A (en) * | 1998-11-24 | 2000-05-16 | Novo Nordisk Biotech, Inc. | Polypeptides having choline oxidase activity and nucleic acids encoding same |
CA2405138A1 (en) * | 2000-04-19 | 2001-11-01 | Universidad Politecnica De Valencia | Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
JP2002262885A (ja) | 2001-03-14 | 2002-09-17 | Ajinomoto Co Inc | 植物に対するストレス耐性付与方法 |
JP4755769B2 (ja) * | 2001-03-14 | 2011-08-24 | 独立行政法人理化学研究所 | 植物に対するストレス耐性付与方法 |
CA2462641A1 (en) * | 2001-10-01 | 2003-04-10 | Diversa Corporation | Whole cell engineering using real-time metabolic flux analysis |
WO2003029425A2 (en) * | 2001-10-01 | 2003-04-10 | Diversa Corporation | Whole cell engineering using real-time metabolic flux analysis |
US20060005282A1 (en) * | 2002-04-23 | 2006-01-05 | Activx Biosciences, Inc | Production and use of salt tolerant and culture density tolerant organisms |
DE10260930A1 (de) * | 2002-12-20 | 2004-07-15 | Henkel Kgaa | Neue Cholinoxidasen |
US7410800B2 (en) | 2003-05-05 | 2008-08-12 | Monsanto Technology Llc | Transgenic plants with increased glycine-betaine |
JP2008211968A (ja) * | 2005-06-14 | 2008-09-18 | National Institutes Of Natural Sciences | 花及び/又は果実のサイズが大型化された植物の作出方法 |
US20100186107A1 (en) * | 2009-01-13 | 2010-07-22 | Grain Foods Crc Ltd | Methods of producing improved fragrant plants |
US8040761B2 (en) * | 2009-06-24 | 2011-10-18 | Tdk Corporation | Near-field light generating device including near-field light generating element disposed over waveguide with buffer layer and adhesion layer therebetween |
US9546377B2 (en) * | 2011-10-28 | 2017-01-17 | E I Du Pont De Nemours And Company | Methods for the identification of genes involved in abiotic stress tolerance in plants |
CN112179884A (zh) * | 2020-09-24 | 2021-01-05 | 中国林业科学研究院林业研究所 | 一种快速评价木本植物耐盐碱能力的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024026A1 (fr) | 1995-12-28 | 1997-07-10 | Suntory Limited | Procede d'obtention par recombinaison de plantes insensibles a la temperature |
-
1996
- 1996-03-27 AU AU51203/96A patent/AU709777B2/en not_active Ceased
- 1996-03-27 WO PCT/JP1996/000797 patent/WO1996029857A1/ja active IP Right Grant
- 1996-03-27 AT AT96907665T patent/ATE267260T1/de not_active IP Right Cessation
- 1996-03-27 EP EP96907665A patent/EP0818138B1/en not_active Expired - Lifetime
- 1996-03-27 CA CA002216621A patent/CA2216621A1/en not_active Abandoned
- 1996-03-27 DE DE69632534T patent/DE69632534T2/de not_active Expired - Lifetime
- 1996-03-27 KR KR1019970706787A patent/KR19980703382A/ko not_active Ceased
- 1996-03-27 CN CNB961935022A patent/CN1167800C/zh not_active Expired - Fee Related
- 1996-03-27 US US08/930,001 patent/US6281412B1/en not_active Expired - Fee Related
-
1998
- 1998-10-30 HK HK98111674A patent/HK1018159A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103200814A (zh) * | 2010-10-27 | 2013-07-10 | 韩国生命工学研究院 | 源于蓝细菌的耐盐性SyDBSP基因及其用途 |
CN103200814B (zh) * | 2010-10-27 | 2014-07-23 | 韩国生命工学研究院 | 源于蓝细菌的耐盐性SyDBSP基因及其用途 |
Also Published As
Publication number | Publication date |
---|---|
DE69632534D1 (de) | 2004-06-24 |
CA2216621A1 (en) | 1996-10-03 |
EP0818138A4 (en) | 1999-02-10 |
KR19980703382A (ko) | 1998-10-15 |
AU709777B2 (en) | 1999-09-09 |
EP0818138B1 (en) | 2004-05-19 |
US6281412B1 (en) | 2001-08-28 |
HK1018159A1 (en) | 1999-12-10 |
DE69632534T2 (de) | 2005-06-02 |
CN1167800C (zh) | 2004-09-22 |
WO1996029857A1 (fr) | 1996-10-03 |
AU5120396A (en) | 1996-10-16 |
ATE267260T1 (de) | 2004-06-15 |
EP0818138A1 (en) | 1998-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1182348A (zh) | 产生耐渗透性植物的方法 | |
JP4755109B2 (ja) | 飽和脂肪酸のレベルが低減されたトランスジェニック植物およびその製造方法 | |
US20110268865A1 (en) | Method for increasing photosynthetic carbon fixation in rice | |
EP1171619B1 (en) | Regulated expression of isopentenyl transferase in maize seeds | |
EP1053338A1 (en) | Alteration of amino acid compositions in seeds | |
CN1038465A (zh) | 在植物中诱导赖氨酸过量生成的方法 | |
KR20010005645A (ko) | 식물 종자의 라이신 함량을 증가시키기 위한 키메라 유전자 및 방법 | |
EP1177303A1 (en) | Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof | |
CA2794318A1 (en) | Method of enhancing the seed yield and promoting the growth of plants | |
RU2582260C2 (ru) | Трансгенные растения с улучшенными характеристиками роста | |
JP5273624B2 (ja) | シネコシスティス(Synechocystis)から単離されたSyFBP/SBPase遺伝子を過発現させることによって植物の耐塩性を向上させる方法及びその方法によって製造された植物 | |
JP3961026B2 (ja) | 耐温度性植物の作出方法 | |
Sobha et al. | Genetic transformation of Hevea brasiliensis with the gene coding for superoxide dismutase with FMV 34S promoter | |
CN102286524B (zh) | 一种植物转化载体及其构建方法和应用 | |
RU2169196C2 (ru) | Дезоксирибонуклеиновая кислота, кодирующая белок глутатион-s-трансферазу iiic и белок с соответствующей аминокислотной последовательностью | |
EP1153135B1 (en) | Methods for modulating the levels of organic sulfur compounds in plants | |
KR102080827B1 (ko) | 수발아 저항성을 증진시키는 벼 유래의 OsPHS3 유전자 및 이의 용도 | |
CA2240393C (en) | Method for producing temperature-tolerant plants | |
Hättasch et al. | Evaluation of an alternative D-amino acid/DAAO selection system for transformation in apple (Malus× domestica Borkh.) | |
CN118745432A (zh) | 一种水稻OsPirin基因及其编码的蛋白和应用 | |
CN1390939A (zh) | 脯氨酸蓄积能力高的稻科植物及其生产方法 | |
US20110203019A1 (en) | Methods of producing gaba | |
JP2005006522A (ja) | 耐塩性を選択マーカーとする形質転換植物の作製方法 | |
CN1693469A (zh) | 一种提高异源重组蛋白在转基因植物种子中表达量的方法 | |
FR2803484A1 (fr) | Procede d'obtention de plantes a teneur enrichie en cysteine et glutathion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1018159 Country of ref document: HK |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |